FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Yonke Bob 		2. Issuer Name and Ticker or Trading Symbol

HEALTHTRONICS, INC. [ HTRN ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
President of Urology Services
(Last)          (First)          (Middle)

9825 SPECTRUM DRIVE, BUILDING 3 		3. Date of Earliest Transaction (MM/DD/YYYY)

6/16/2009
(Street)

AUSTIN, TX 78717
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   6/16/2009     D    235631   D (1) (2) $0   849603   D    
Common Stock   6/16/2009     A    235631   A (1) (2) $0   1085234   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
( 1)  On June 16, 2009, in connection with the termination of Mr. Yonke's employment relationship and the entering into of a consulting arrangement with Mr. Yonke, HealthTronics, Inc. (the "Company") agreed to amend Mr. Yonke's restricted stock award to (1) provide that Mr. Yonke will continue to vest in his restricted stock awards until July 16, 2010 (the expiration date of the consulting arrangement) and (2) eliminate the vesting requirement that Mr. Yonke not have voluntarily terminated his employment with the Company prior to the second anniversary of the date of grant. This amendment results in a deemed cancellation of the "original" restricted stock award and the grant of a replacement restricted stock award. Accordingly, Mr. Yonke's restricted stock award vests as follows:
( 2)  a) 82,470 shares vest one-fourth on each of the first four anniversaries of the date of grant (20,617 shares on the first two anniversaries and 20,618 on each of the third and fourth anniversaries), provided, that vesting of such shares will be accelerated based on the achievement of the performance targets in (b) below within the first two years after the date of grant (in order starting with the first one-fourth unvested tranche next scheduled to vest) and (b) 153,161 shares vest based on the achievement of the following performance targets (shares that have not vested by July 16, 2010 will be forfeited): 20-day average closing price of Company common stock on any trading day after the grant date as a % of the closing price of Company common stock on the grant date Percentage of shares that vests 115% 25% 130% 50% 145% 75% 160% 100%

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Yonke Bob
9825 SPECTRUM DRIVE
BUILDING 3
AUSTIN, TX 78717

President of Urology Services

Signatures
/s/ Robert Yonke 12/3/2009
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Htetf (MM) (NASDAQ:HTRN)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Htetf (MM) Charts.
Htetf (MM) (NASDAQ:HTRN)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Htetf (MM) Charts.